Health Catalyst, Inc. (HCAT)
1.75
+0.05
(+2.94%)
USD |
NASDAQ |
Oct 02, 16:00
1.745
0.00 (0.00%)
After-Hours: 20:00
Health Catalyst Gross Profit Margin (Quarterly) : 34.67% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 34.67% |
| March 31, 2026 | 33.43% |
| December 31, 2025 | 35.50% |
| September 30, 2025 | 34.49% |
| June 30, 2025 | 31.95% |
| March 31, 2025 | 32.12% |
| December 31, 2024 | 30.90% |
| September 30, 2024 | 31.77% |
| June 30, 2024 | 33.47% |
| March 31, 2024 | 34.92% |
| December 31, 2023 | 29.63% |
| September 30, 2023 | 29.76% |
| June 30, 2023 | 31.70% |
| March 31, 2023 | 34.10% |
| December 31, 2022 | 29.99% |
| September 30, 2022 | 29.05% |
| June 30, 2022 | 33.48% |
| March 31, 2022 | 33.44% |
| December 31, 2021 | 30.92% |
| Date | Value |
|---|---|
| September 30, 2021 | 29.31% |
| June 30, 2021 | 35.95% |
| March 31, 2021 | 37.06% |
| December 31, 2020 | 35.62% |
| September 30, 2020 | 37.84% |
| June 30, 2020 | 39.38% |
| March 31, 2020 | 40.28% |
| December 31, 2019 | 44.73% |
| September 30, 2019 | 46.86% |
| June 30, 2019 | 45.86% |
| March 31, 2019 | 44.54% |
| December 31, 2018 | 42.13% |
| September 30, 2018 | 42.75% |
| June 30, 2018 | 38.80% |
| March 31, 2018 | 36.22% |
| December 31, 2017 | 47.04% |
| September 30, 2017 | 31.57% |
| June 30, 2017 | 24.77% |
| March 31, 2017 | 21.47% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| LataMed AI Corp. | -- |
| SCWorx Corp. | 26.95% |
| GoodRx Holdings, Inc. | 78.41% |
| Claritev Corp. | 30.72% |
| iSpecimen, Inc. | -87.43% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -113.7% |
| Return on Assets | -53.46% |
| Return on Invested Capital | -65.52% |
| Profit Margin (Quarterly) | -57.51% |
| Operating Margin (Quarterly) | -5.35% |
| Return on Net Operating Assets | -73.15% |